INSYS Therapeutics
- Pharmaceutical Preparations
- Phoenix, Arizona
Compensation history
Top executives at INSYS Therapeutics received an average of $2M per person in annual compensation from 2013 to 2017.
Average pay of disclosed executives at INSYS Therapeutics
By year
- 2017
SM$4MSaeed MotahariPresident, CEO and DirectorFD$1MFranc Del FosseGeneral Counsel & Corporate SecretaryAL$1MAndrew G. LongChief Financial OfficerDB$999KDarryl S. BakerFormer Chief Financial OfficerSV$951KSantosh VetticadenFormer Interim CEO and CMOJK$96KJohn N. KapoorFormer President, CEO and Chairman
Executives
We found eight executives who work or worked at INSYS Therapeutics.
Saeed Motahari
INSYS Therapeutics
Chief Executive Officer
Andrew Long
INSYS Therapeutics
Chief Financial Officer
Franc Del Fosse
INSYS Therapeutics
General Counsel
John Kapoor
INSYS Therapeutics
Chief Executive Officer
Santosh Vetticaden
INSYS Therapeutics
Chief Executive Officer
Darryl Baker
INSYS Therapeutics
Chief Financial Officer
Daniel Brennan
INSYS Therapeutics
Chief Operating Officer
Michael Babich
INSYS Therapeutics
Chief Executive Officer
News
About INSYS Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address10220 South 51st Street, Suite 2, Phoenix, Arizona 85044
- Phone602-910-2617
- Fiscal year endDecember 31
Source: SEC filings on April 16, 2018, April 17, 2017, and April 19, 2016.